Global Neurovascular Stent Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Neurovascular Stent Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Neurovascular Stent Market Size Growth Rate by Product
- 1.4.2 Carotid artery stents
- 1.4.3 Intracranial stents
- 1.5 Market by End User
- 1.5.1 Global Neurovascular Stent Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Ambulatory Surgical Centers
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Neurovascular Stent Market Size
- 2.1.1 Global Neurovascular Stent Revenue 2014-2025
- 2.1.2 Global Neurovascular Stent Sales 2014-2025
- 2.2 Neurovascular Stent Growth Rate by Regions
- 2.2.1 Global Neurovascular Stent Sales by Regions
- 2.2.2 Global Neurovascular Stent Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Neurovascular Stent Sales by Manufacturers
- 3.1.1 Neurovascular Stent Sales by Manufacturers
- 3.1.2 Neurovascular Stent Sales Market Share by Manufacturers
- 3.1.3 Global Neurovascular Stent Market Concentration Ratio (CR5 and HHI)
- 3.2 Neurovascular Stent Revenue by Manufacturers
- 3.2.1 Neurovascular Stent Revenue by Manufacturers (2014-2019)
- 3.2.2 Neurovascular Stent Revenue Share by Manufacturers (2014-2019)
- 3.3 Neurovascular Stent Price by Manufacturers
- 3.4 Neurovascular Stent Manufacturing Base Distribution, Product Types
- 3.4.1 Neurovascular Stent Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Neurovascular Stent Product Type
- 3.4.3 Date of International Manufacturers Enter into Neurovascular Stent Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Neurovascular Stent Sales by Product
- 4.2 Global Neurovascular Stent Revenue by Product
- 4.3 Neurovascular Stent Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Neurovascular Stent Breakdown Data by End User
6 North America
- 6.1 North America Neurovascular Stent by Countries
- 6.1.1 North America Neurovascular Stent Sales by Countries
- 6.1.2 North America Neurovascular Stent Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Neurovascular Stent by Product
- 6.3 North America Neurovascular Stent by End User
7 Europe
- 7.1 Europe Neurovascular Stent by Countries
- 7.1.1 Europe Neurovascular Stent Sales by Countries
- 7.1.2 Europe Neurovascular Stent Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Neurovascular Stent by Product
- 7.3 Europe Neurovascular Stent by End User
8 Asia Pacific
- 8.1 Asia Pacific Neurovascular Stent by Countries
- 8.1.1 Asia Pacific Neurovascular Stent Sales by Countries
- 8.1.2 Asia Pacific Neurovascular Stent Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Neurovascular Stent by Product
- 8.3 Asia Pacific Neurovascular Stent by End User
9 Central & South America
- 9.1 Central & South America Neurovascular Stent by Countries
- 9.1.1 Central & South America Neurovascular Stent Sales by Countries
- 9.1.2 Central & South America Neurovascular Stent Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Neurovascular Stent by Product
- 9.3 Central & South America Neurovascular Stent by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Neurovascular Stent by Countries
- 10.1.1 Middle East and Africa Neurovascular Stent Sales by Countries
- 10.1.2 Middle East and Africa Neurovascular Stent Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Neurovascular Stent by Product
- 10.3 Middle East and Africa Neurovascular Stent by End User
11 Company Profiles
- 11.1 Abbott Laboratories (USA)
- 11.1.1 Abbott Laboratories (USA) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abbott Laboratories (USA) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abbott Laboratories (USA) Neurovascular Stent Products Offered
- 11.1.5 Abbott Laboratories (USA) Recent Development
- 11.2 Gore Medical (USA)
- 11.2.1 Gore Medical (USA) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Gore Medical (USA) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Gore Medical (USA) Neurovascular Stent Products Offered
- 11.2.5 Gore Medical (USA) Recent Development
- 11.3 Terumo Medical (Japan)
- 11.3.1 Terumo Medical (Japan) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Terumo Medical (Japan) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Terumo Medical (Japan) Neurovascular Stent Products Offered
- 11.3.5 Terumo Medical (Japan) Recent Development
- 11.4 Johnson & Johnson (USA)
- 11.4.1 Johnson & Johnson (USA) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Johnson & Johnson (USA) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Johnson & Johnson (USA) Neurovascular Stent Products Offered
- 11.4.5 Johnson & Johnson (USA) Recent Development
- 11.5 Medtronic (USA)
- 11.5.1 Medtronic (USA) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Medtronic (USA) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Medtronic (USA) Neurovascular Stent Products Offered
- 11.5.5 Medtronic (USA) Recent Development
- 11.6 Acandis (Germany)
- 11.6.1 Acandis (Germany) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Acandis (Germany) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Acandis (Germany) Neurovascular Stent Products Offered
- 11.6.5 Acandis (Germany) Recent Development
- 11.7 Stryker (USA)
- 11.7.1 Stryker (USA) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Stryker (USA) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Stryker (USA) Neurovascular Stent Products Offered
- 11.7.5 Stryker (USA) Recent Development
- 11.8 MicroPort Scientific (China)
- 11.8.1 MicroPort Scientific (China) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 MicroPort Scientific (China) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 MicroPort Scientific (China) Neurovascular Stent Products Offered
- 11.8.5 MicroPort Scientific (China) Recent Development
- 11.9 Cordis (USA)
- 11.9.1 Cordis (USA) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Cordis (USA) Neurovascular Stent Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Cordis (USA) Neurovascular Stent Products Offered
- 11.9.5 Cordis (USA) Recent Development
12 Future Forecast
- 12.1 Neurovascular Stent Market Forecast by Regions
- 12.1.1 Global Neurovascular Stent Sales Forecast by Regions 2019-2025
- 12.1.2 Global Neurovascular Stent Revenue Forecast by Regions 2019-2025
- 12.2 Neurovascular Stent Market Forecast by Product
- 12.2.1 Global Neurovascular Stent Sales Forecast by Product 2019-2025
- 12.2.2 Global Neurovascular Stent Revenue Forecast by Product 2019-2025
- 12.3 Neurovascular Stent Market Forecast by End User
- 12.4 North America Neurovascular Stent Forecast
- 12.5 Europe Neurovascular Stent Forecast
- 12.6 Asia Pacific Neurovascular Stent Forecast
- 12.7 Central & South America Neurovascular Stent Forecast
- 12.8 Middle East and Africa Neurovascular Stent Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Neurovascular Stent Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
A neurovascular stent is a small, tube-like, flexible device that is made of either metal or polymer.
The global Neurovascular Stent market is valued at 520 million US$ in 2018 and will reach 1320 million US$ by the end of 2025, growing at a CAGR of 12.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neurovascular Stent market based on company, product type, end user and key regions.
This report studies the global market size of Neurovascular Stent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neurovascular Stent in these regions.
This research report categorizes the global Neurovascular Stent market by top players/brands, region, type and end user. This report also studies the global Neurovascular Stent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories (USA)
Gore Medical (USA)
Terumo Medical (Japan)
Johnson & Johnson (USA)
Medtronic (USA)
Acandis (Germany)
Stryker (USA)
MicroPort Scientific (China)
Cordis (USA)
Market size by Product
Carotid artery stents
Intracranial stents
Market size by End User
Hospitals
Ambulatory Surgical Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Neurovascular Stent market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neurovascular Stent market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neurovascular Stent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neurovascular Stent submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Neurovascular Stent are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neurovascular Stent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.